Cambridge UK medical device specialist, Sphere Medical, is pushing its technology into Japan.The company has appointed a Tokyo business as exclusive distributor for its Pelorus 1000 propofol measurement system in the Japanese market.
Sphere Medical, which develops innovative monitoring and diagnostic products for the critical care setting, has tied up with Finggal Link Co, which distributes medical and life sciences equipment, including a range of in-vitro diagnostic and analytical kit.
The company’s sales and service force delivers full geographic coverage across Japan.
The Pelorus 1000 is said to be the world’s first commercially available rapid propofol analyser.
Propofol is widely used in critical care, for general anaesthesia in the operating room and for sedation in the intensive care unit. The ability to measure and adjust propofol levels is expected to be a key tool in individualising and optimising therapy at the patient level, both in the operating room and the intensive care unit.
Stuart Hendry, Sphere Medical’s, said: “Finggal Link has been supporting our activities in Japan for the last few months and we are very pleased that this has progressed to a full distribution agreement.
“Japan is an important market for new medical technologies and Finggal Link has a strong record in the introduction of such technologies to the anaesthesiologist.”